Ultrasound-Mediated Gene Transfection

  • Loreto B. FerilJr.Email author
Part of the Methods in Molecular Biology™ book series (MIMB, volume 542)


Ultrasound-mediated gene transfection (sonotransfection) has been shown to be a promising physical method for gene therapy, especially for cancer gene therapy. The procedure being done in vitro uses several ultrasound exposure (sonication) setups. Although high transfection rates have been attained in some of these setups in vitro, replicating similar levels of transfection in vivo has been difficult. In vivo-simulated setups offer hope for a more consistent outcome in vivo. Presented in this chapter are typical methods of sonotransfection in vitro, methods when using a novel in vivo-simulated in vitro sonication setup and also sonotransfection methods when doing in vivo experiments. Factors that could potentially influence the outcome of an ultrasound experiment are cited. Several advantages of sonotransfection are recognized, although a low transfection rate is still considered a disadvantage of this method. To improve the transfection rate and the efficiency of sonotransfection, several studies are currently being undertaken. Particularly promising are studies using engineered microbubbles to carry the therapeutic genes into a particular target tissue in the body, then using ultrasound to release or deliver the genes directly into target cells, e.g., cancer cells.

Key Words

Cancer therapy HIFU sonotransfection ultrasound-mediated transfection 


  1. 1.
    ter Haar GR. (2001) High intensity focused ultrasound for the treatment of tumors. Echocardiography 18:317–22.PubMedCrossRefGoogle Scholar
  2. 2.
    Feril LB, Jr., Kondo T. (2004) Biological effects of low intensity ultrasound: the mechanism involved, and its implications on therapy and on biosafety of ultrasound. Journal of Radiation Research 45:479–89.PubMedCrossRefGoogle Scholar
  3. 3.
    Feril LB, Jr., Ogawa R, Tachibana K, Kondo T. (2006) Optimized ultrasound-mediated gene transfection in cancer cells. Cancer Science 97:1111–4.PubMedCrossRefGoogle Scholar
  4. 4.
    Wu F, Wang ZB, Chen WZ, et al. (2004) Extracorporeal high intensity focused ultrasound ablation in the treatment of 1038 patients with solid carcinomas in China: an overview. Ultrasonics Sonochemistry 11:149–54.PubMedCrossRefGoogle Scholar
  5. 5.
    Uchida T, Baba S, Irie A, et al. (2005) Transrectal high-intensity focused ultrasound in the treatment of localized prostate cancer: a multicenter study. Hinyokika Kiyo – Acta Urologica Japonica 51:651–8.PubMedGoogle Scholar
  6. 6.
    Chaussy C, Thuroff S, Rebillard X, Gelet A. (2005) Technology insight: high-intensity focused ultrasound for urologic cancers. Nature Clinical Practice Urology 2:191–8.PubMedCrossRefGoogle Scholar
  7. 7.
    Wu F, ter Haar G, Chen WR. (2007) High-intensity focused ultrasound ablation of breast cancer. Expert Review of Anticancer Therapy 7:823–31.PubMedCrossRefGoogle Scholar
  8. 8.
    Chan AH, Fujimoto VY, Moore DE, Martin RW, Vaezy S. (2002) An image-guided high intensity focused ultrasound device for uterine fibroids treatment. Medical Physics 29:2611–20.PubMedCrossRefGoogle Scholar
  9. 9.
    Feril LB, Jr., Kondo T. (2005) Major factors involved in the inhibition of ultrasound-induced free radical production and cell killing by pre-sonication incubation or by high cell density. Ultrasonics Sonochemistry 12:353–7.PubMedCrossRefGoogle Scholar
  10. 10.
    Feril LB, Jr., Kondo T, Takaya K, Riesz P. (2004) Enhanced ultrasound-induced apoptosis and cell lysis by a hypotonic medium. International Journal of Radiation Biology 80:165–75.PubMedCrossRefGoogle Scholar
  11. 11.
    Vessey CJ, Norbury CJ, Hickson ID. (1999) Genetic disorders associated with cancer predisposition and genomic instability. Progress in Nucleic Acid Research & Molecular Biology 63:189–221.CrossRefGoogle Scholar
  12. 12.
    Uesato M, Gunji Y, Tomonaga T, et al. (2004) Synergistic antitumor effect of antiangiogenic factor genes on colon 26 produced by low-voltage electroporation. Cancer Gene Therapy 11:625–32.PubMedCrossRefGoogle Scholar
  13. 13.
    Kikuchi A, Aoki Y, Sugaya S, et al. (1999) Development of novel cationic liposomes for efficient gene transfer into peritoneal disseminated tumor. Human Gene Therapy 10:947–55.PubMedCrossRefGoogle Scholar
  14. 14.
    Bloquel C, Fabre E, Bureau MF, Scherman D. (2004) Plasmid DNA electrotransfer for intracellular and secreted proteins expression: new methodological developments and applications. Journal of Gene Medicine 6 (Suppl 1):S11–23.PubMedCrossRefGoogle Scholar
  15. 15.
    Feril LB, Jr., Kondo T, Zhao QL, Ogawa R. (2002) Enhancement of hyperthermia-induced apoptosis by non-thermal effects of ultrasound. Cancer Letters 178:63–70.PubMedCrossRefGoogle Scholar
  16. 16.
    Nozaki T, Ogawa R, Feril LB, Jr., Kagiya G, Fuse H, Kondo T. (2003) Enhancement of ultrasound-mediated gene transfection by membrane modification. Journal of Gene Medicine 5:1046–55.PubMedCrossRefGoogle Scholar
  17. 17.
    Ogawa R, Kagiya G, Feril LB, Jr., et al. (2004) Ultrasound mediated intravesical transfection enhanced by treatment with lidocaine or heat [see comment]. Journal of Urology 172:1469–73.PubMedCrossRefGoogle Scholar
  18. 18.
    Lawrie A, Brisken AF, Francis SE, et al. (2003) Ultrasound-enhanced transgene expression in vascular cells is not dependent upon cavitation-induced free radicals. Ultrasound in Medicine & Biology 29:1453–61.CrossRefGoogle Scholar
  19. 19.
    Feril LB, Jr., Ogawa R, Kobayashi H, Kikuchi H, Kondo T. (2005) Ultrasound enhances liposome-mediated gene transfection. Ultrasonics Sonochemistry 12:489–93.PubMedCrossRefGoogle Scholar
  20. 20.
    Yoshida T, Ohnami S, Aoki K. (2004) Development of gene therapy to target pancreatic cancer. Cancer Science 95:283–9.PubMedCrossRefGoogle Scholar
  21. 21.
    Prentice P, A. Cuschieri, K. Dholakia, Mark Prausnitz, and P. Campbell. (2005) Membrane disruption by optically controlled microbubble cavitation. Nature Physics 1:107–10.CrossRefGoogle Scholar
  22. 22.
    Feril LB, Jr., Tsuda Y, Kondo T, et al. (2004) Ultrasound-induced killing of monocytic U937 cells enhanced by 2,2'-azobis(2-amidinopropane) dihydrochloride. Cancer Science 95:181–5.PubMedCrossRefGoogle Scholar
  23. 23.
    Feril LB, Jr., Kondo T, Cui ZG, et al. (2005) Apoptosis induced by the sonomechanical effects of low intensity pulsed ultrasound in a human leukemia cell line. Cancer Letters 221:145–52.PubMedCrossRefGoogle Scholar
  24. 24.
    Ogawa R, Kondo T, Honda H, Zhao QL, Fukuda S, Riesz P. (2002) Effects of dissolved gases and an echo contrast agent on ultrasound mediated in vitro gene transfection. Ultrasonics Sonochemistry 9:197–203.PubMedCrossRefGoogle Scholar
  25. 25.
    Yamashita Y, Shimada M, Tachibana K, et al. (2002) In vivo gene transfer into muscle via electro-sonoporation. Human Gene Therapy 13:2079–84.PubMedCrossRefGoogle Scholar
  26. 26.
    Feril LB, Jr., Kondo T, Ogawa R, Zhao QL. (2003) Dose-dependent inhibition of ultrasound-induced cell killing and free radical production by carbon dioxide. Ultrasonics Sonochemistry 10:81–4.PubMedCrossRefGoogle Scholar
  27. 27.
    Kondo T, Kuwabara M, Sato F, Kano E. (1986) Influence of dissolved gases on chemical and biological effects of ultrasound. Ultrasound in Medicine & Biology 12:151–5.CrossRefGoogle Scholar
  28. 28.
    Kondo T, Kano E. (1987) Enhancement of hyperthermic cell killing by non-thermal effect of ultrasound. International Journal of Radiation Biology & Related Studies in Physics, Chemistry & Medicine 51:157–66.CrossRefGoogle Scholar
  29. 29.
    Feril LB, Jr., Kondo T, Tabuchi Y, et al. (2007) Biomolecular effects of low-intensity ultrasound: apoptosis, sonotransfection, gene expression. Japanese Journal of Applied Physics 46:4435–40.CrossRefGoogle Scholar

Copyright information

© Humana Press, a part of Springer Science+Business Media, LLC 2009

Authors and Affiliations

  1. 1.Department of AnatomyFukuoka University School of MedicineFukuokaJapan

Personalised recommendations